These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Proteomic Landscape of a Drug-Tolerant Persister Subpopulation of Sharma R; Lunge A; Mangla N; Agarwal N J Proteome Res; 2021 Sep; 20(9):4415-4426. PubMed ID: 34343006 [TBL] [Abstract][Full Text] [Related]
3. Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Eoh H; Liu R; Lim J; Lee JJ; Sell P Front Cell Infect Microbiol; 2022; 12():958240. PubMed ID: 36072228 [TBL] [Abstract][Full Text] [Related]
5. Multidrug tolerance of biofilms and persister cells. Lewis K Curr Top Microbiol Immunol; 2008; 322():107-31. PubMed ID: 18453274 [TBL] [Abstract][Full Text] [Related]
7. Noise in a Metabolic Pathway Leads to Persister Formation in Mycobacterium tuberculosis. Quigley J; Lewis K Microbiol Spectr; 2022 Oct; 10(5):e0294822. PubMed ID: 36194154 [TBL] [Abstract][Full Text] [Related]
8. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells. Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K mBio; 2017 Dec; 8(6):. PubMed ID: 29233898 [TBL] [Abstract][Full Text] [Related]
10. ATP-Dependent Persister Formation in Escherichia coli. Shan Y; Brown Gandt A; Rowe SE; Deisinger JP; Conlon BP; Lewis K mBio; 2017 Feb; 8(1):. PubMed ID: 28174313 [TBL] [Abstract][Full Text] [Related]
11. Candida albicans biofilms produce antifungal-tolerant persister cells. LaFleur MD; Kumamoto CA; Lewis K Antimicrob Agents Chemother; 2006 Nov; 50(11):3839-46. PubMed ID: 16923951 [TBL] [Abstract][Full Text] [Related]
12. Survival of bactericidal antibiotic treatment by a persister subpopulation of Listeria monocytogenes. Knudsen GM; Ng Y; Gram L Appl Environ Microbiol; 2013 Dec; 79(23):7390-7. PubMed ID: 24056460 [TBL] [Abstract][Full Text] [Related]
14. The Role of Integration Host Factor in Escherichia coli Persister Formation. Nicolau SE; Lewis K mBio; 2022 Feb; 13(1):e0342021. PubMed ID: 34982597 [TBL] [Abstract][Full Text] [Related]
15. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. Deb C; Lee CM; Dubey VS; Daniel J; Abomoelak B; Sirakova TD; Pawar S; Rogers L; Kolattukudy PE PLoS One; 2009 Jun; 4(6):e6077. PubMed ID: 19562030 [TBL] [Abstract][Full Text] [Related]
16. Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals. Grant SS; Kaufmann BB; Chand NS; Haseley N; Hung DT Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12147-52. PubMed ID: 22778419 [TBL] [Abstract][Full Text] [Related]
17. Zebrafish Embryo Model for Assessment of Drug Efficacy on Mycobacterial Persisters. Commandeur S; Iakobachvili N; Sparrius M; Nur MM; Mukamolova GV; Bitter W Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32778551 [TBL] [Abstract][Full Text] [Related]
18. Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. Keren I; Minami S; Rubin E; Lewis K mBio; 2011; 2(3):e00100-11. PubMed ID: 21673191 [TBL] [Abstract][Full Text] [Related]